Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (17)

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Eradication of hepatitis C virus and non-liver-related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection

    Hepatology, Vol. 66, Núm. 2, pp. 344-356

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Genetic barrier to resistance for dolutegravir

    AIDS Reviews, Vol. 17, Núm. 1, pp. 59-68

  2. Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

    AIDS, Vol. 28, Núm. 9, pp. 1279-1287

2013

  1. Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

    Journal of Hepatology, Vol. 58, Núm. 6, pp. 1104-1112

2012

  1. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with hiv and hepatitis c virus

    Clinical Infectious Diseases, Vol. 55, Núm. 5, pp. 728-736

  2. Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists

    AIDS Reviews, Vol. 14, Núm. 3, pp. 208-217

2011

  1. Clinical utility of maraviroc

    Clinical Drug Investigation, Vol. 31, Núm. 8, pp. 527-542

  2. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2010

  1. Genotypic determination of HIV tropism - Clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

    AIDS Reviews, Vol. 12, Núm. 3, pp. 135-148

2009

  1. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

    Hepatology, Vol. 50, Núm. 2, pp. 407-413

2007

  1. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: The CORAL-1 multicentre pilot study

    Journal of Viral Hepatitis, Vol. 14, Núm. 10, pp. 704-713

2006

  1. Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 2, pp. 96-117

2005

  1. GEAM/SPNS recommendations for managing metabolic and morphologic alterations in patients with HIV infection

    Nutrition and Metabolic Disorders in HIV Infection, Vol. 4, Núm. 2, pp. 617-698

2000

  1. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires

    AIDS, Vol. 14, Núm. 10, pp. 1439-1447

1999

  1. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients

    AIDS, Vol. 13, Núm. 13, pp. 1727-1735